146 related articles for article (PubMed ID: 37094546)
41. Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene.
Gruszka-Westwood AM; Atkinson S; Summersgill BM; Shipley J; Elnenaei MO; Jain P; Hamoudi RA; Kaeda JS; Wotherspoon AC; Matutes E; Catovsky D
Genes Chromosomes Cancer; 2002 Feb; 33(2):206-12. PubMed ID: 11793447
[TBL] [Abstract][Full Text] [Related]
42. Detection of cryptic CCND1 rearrangements in mantle cell lymphoma by next generation sequencing.
Polonis K; Schultz MJ; Olteanu H; Smadbeck JB; Johnson SH; Vasmatzis G; Xu X; Greipp PT; Ketterling RP; Hoppman NL; Baughn LB; Peterson JF
Ann Diagn Pathol; 2020 Jun; 46():151533. PubMed ID: 32408254
[TBL] [Abstract][Full Text] [Related]
43. Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report.
Loungani L; Mundhe R; Chinoy R
Int J Surg Pathol; 2022 Apr; 30(2):190-194. PubMed ID: 34180720
[TBL] [Abstract][Full Text] [Related]
44. Burkitt transformation of mantle cell lymphoma.
Felten CL; Stephenson CF; Ortiz RO; Hertzberg L
Leuk Lymphoma; 2004 Oct; 45(10):2143-7. PubMed ID: 15370262
[TBL] [Abstract][Full Text] [Related]
45. Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?
Ortega V; Mendiola C; Rodriguez J; Ehman W; Qian YW; Velagaleti G
Mol Cytogenet; 2021 Feb; 14(1):8. PubMed ID: 33541390
[TBL] [Abstract][Full Text] [Related]
46. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
[TBL] [Abstract][Full Text] [Related]
47. The pathologic diagnosis of mantle cell lymphoma.
Li S; Xu J; You MJ
Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
[TBL] [Abstract][Full Text] [Related]
48. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
[TBL] [Abstract][Full Text] [Related]
49. Cytogenetic findings in blastoid mantle cell lymphoma.
Khoury JD; Sen F; Abruzzo LV; Hayes K; Glassman A; Medeiros LJ
Hum Pathol; 2003 Oct; 34(10):1022-9. PubMed ID: 14608536
[TBL] [Abstract][Full Text] [Related]
50. Blastic mantle cell lymphoma with a Burkitt translocation.
Reddy K; Ansari-Lari M; Dipasquale B
Leuk Lymphoma; 2008 Apr; 49(4):740-50. PubMed ID: 18398742
[TBL] [Abstract][Full Text] [Related]
51. Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma.
Drexler HG; MacLeod RA
Leuk Res; 2002 Sep; 26(9):781-7. PubMed ID: 12127550
[TBL] [Abstract][Full Text] [Related]
52. Mantle cell lymphoma--a spectrum from indolent to aggressive disease.
Sander B; Quintanilla-Martinez L; Ott G; Xerri L; Kuzu I; Chan JK; Swerdlow SH; Campo E
Virchows Arch; 2016 Mar; 468(3):245-57. PubMed ID: 26298543
[TBL] [Abstract][Full Text] [Related]
53. Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma.
Bacher U; Kern W; Haferlach C; Alpermann T; Haferlach T; Schnittger S
Exp Hematol; 2013 Dec; 41(12):1028-37. PubMed ID: 24060591
[TBL] [Abstract][Full Text] [Related]
54. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S
Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553
[TBL] [Abstract][Full Text] [Related]
55. The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.
Slotta-Huspenina J; Koch I; de Leval L; Keller G; Klier M; Bink K; Kremer M; Raffeld M; Fend F; Quintanilla-Martinez L
Haematologica; 2012 Sep; 97(9):1422-30. PubMed ID: 22315488
[TBL] [Abstract][Full Text] [Related]
56. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
[TBL] [Abstract][Full Text] [Related]
57. Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients.
Hu Z; Medeiros LJ; Chen Z; Chen W; Li S; Konoplev SN; Lu X; Pham LV; Young KH; Wang W; Hu S
Am J Surg Pathol; 2017 Feb; 41(2):216-224. PubMed ID: 27776009
[TBL] [Abstract][Full Text] [Related]
58. Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14.
Aventín A; Nomdedéu J; Briones J; Espinosa I; Bordes R; Sierra J
J Clin Pathol; 2003 Oct; 56(10):798-800. PubMed ID: 14514791
[TBL] [Abstract][Full Text] [Related]
59. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
[No Abstract] [Full Text] [Related]
60. Fluorescence in situ hybridization: method of choice for a definitive diagnosis of mantle cell lymphoma.
Sun T; Nordberg ML; Cotelingam JD; Veillon DM; Ryder J
Am J Hematol; 2003 Sep; 74(1):78-84. PubMed ID: 12949897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]